Latest Biotechnology, Pharmaceutical and Healthcare News from BioPharma-Reporter

09:10 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "BioPharma-Reporter" found in our extensive news archives from over 250 global news sources.

More Information about BioPharma-Reporter on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioPharma-Reporter for you to read. Along with our medical data and news we also list BioPharma-Reporter Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPharma-Reporter Companies for you to search.

Showing News Articles 1–25 of 325 from BioPharma-Reporter

Friday 21st September 2018

Lonza invests $418m in two biomanufacturing solutions

Lonza announced it would invest in two new âIbex Solutionsâ, which offer manufacturing capabilities to biotechs developing antibody therapies.

TriLink BioTechnologies to relocate to expand operations

TriLink BioTechnologies, a subsidiary of Maravai, that provides gene therapy services to researchers, has announced it will relocate to expand the companyâs operations.

Novartis ‘disappointed’ and ‘surprised’ by NICE CAR-T call

NICE has deemed Novartisâ CAR T-cell therapy Kymriah too expensive for the UK market.

Thursday 20th September 2018

Hired and Retired: Big pharma to biotech trend continues

As the stream of executives flowing from large pharma companies to smaller biotechs builds into a torrent, another month has passed with a number of significant switches. Notably, two former Genentech employees, responsible for work on some of its bestselling products, have made the move to become executives at a very early stage biotech that has only just completed a Series B financing.

Wednesday 19th September 2018

Partnership to provide oncology portfolio with a translational platform

Mitra Biotech and Glenmark Pharmaceuticals have partnered to advance research on Glenmarkâs immuno-oncology treatments using Mitraâs platform.

Test may determine if immunogloubin can help treat autism

A study demonstrated that IV immunogloubin may be able to help treat a subset of individuals with autism spectrum disorder.

Novo Nordisk creates four R&D centres by shedding 400 jobs

Novo Nordisk will restructure its R&D operations through the increased investment made possible by laying off 400 members of staff.

Tuesday 18th September 2018

US FDA eases Teva headache with Ajovy approval

Regulatory setbacks at Tevaâs CMO facility in Korea have not halted the regulatory progression of preventive migraine treatment Ajovy, which has received US FDA approval.

Oncology vaccine ensured 100% survival rate in lab studies

Scientists demonstrated that an adjuvant to an immunotherapy vaccine resulted in a 100% survival rate in mice with aggressive melanoma.

Boehringer buys ViraTherapeutics to help make ‘cold’ tumours ‘hot’

Boehringer Ingelheim will pay â210m for ViraTherapeutics to boost viral-based immune-oncology R&D.

Monday 17th September 2018

How the US-Mexico trade deal could impact the biologics market

BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lioneâs biopharma practice group, the provisional detail revealed from the US administrationâs proposed trade deal with Mexico, and its potential impact on the biopharma industry.

Friday 14th September 2018

The third generation of large molecule drugs? Controlled-release biologics, says DelSiTech

According to DelSiTech, biodegradable parenteral drug delivery technology could help create a âpatient-friendly approachâ to biologics delivery.

Thermo Fisher expands bioprocessing with BD acquisition

Thermo Fisher Scientific announced the acquisition of BDâs Advanced Bioprocessing unit, which will join its Life Sciences Solution business.

Thursday 13th September 2018

Missed #NSLDays in Sweden? Live dispatches from Stockholm

As Nordic Life Science Days draws to a close for 2018, so too do the conference âsuper sessionsâ, covering patient engagement, precision medicine, drug delivery and immune-oncology. Biopharma-Reporter is on the ground, bringing you the social media buzz direct from Scandinavia.

Wednesday 12th September 2018

3M aims to clean up with updated purifier product

3M used the platform of Biotech Week Boston to discuss its updated Emphaze AEX Hybrid Purifier product.

Morphogenesis initiates first in-human clinical trial after working with companion animals

Morphogenesis launched its first in-human melanoma clinical study with Moffitt Cancer Center, as part of Moffittâs Cutaneous Oncology Program.

Swedish biotech targets baldness with ‘serendipitous’ R&D

A fortuitous finding in preclinical research, whereby mice injected with a modified protein developed hair, has prompted Follicum ABâs research and development into the alopecia space.

Tuesday 11th September 2018

GSK hit with US FDA knockback for COPD application

GlaxoSmithKline received a rejection for the use of its Nucala product in patients with COPD.

MilliporeSigma claims ‘first-of-its-kind’ resin improves efficiency across the board

MilliporeSigma used Biotech Week Boston to discuss the release of its Eshmuno CP-FT resin and how it can improve downstream efficiency.

Seqirus receives FDA approval on cell-based flu vaccine manufacturing process

Seqirus received approval on its cell-based flu vaccine manufacturing process from the FDA, not long after its FY18 earnings showed profitability.

Friday 7th September 2018

Researcher develops ‘100x more effective’ solid tumor antibody therapy

A researcher at UVA medical school has developed a âtwo-headedâ antibody approach to treat ovarian cancer and solid tumors.

Research shows cancer-targeting immunotherapy inhibits tumor growth

A research team at VIB-UGent developed an immunotherapy treatment that destroyed tumors while stimulating the immune system in mice which may improve efficacy of checkpoint inhibitors.

CAR-T for kids: Kymriah enters under-25s market in UK

The NHS has signed a commercial deal with Novartis, which will see âgame changerâ therapy Kymriah supplied to children and young people in the UK.

Thursday 6th September 2018

The latest updates from Biotech Week Boston

BioProcess International has kicked off at Biotech Week Boston. BioPharma-Reporter is here to cover the best of the sessions and the reactions from everyone present.

Wednesday 5th September 2018

Bio-Thera expect to have ‘first approved Humira biosimilar’ in China

The CDNA has accepted Bio-Thera Solutions BLA for a biosimilar to Humira for review.

Quick Search


News Quicklinks